BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million

Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...

February 26, 2024 | News

RSSL Launches Innovation Hub for Biotech Support with Labs and Services

RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...

February 22, 2024 | News

Hox Therapeutics and Vernalis Enter Collaboration to Advance Oncology Drug Discovery

Hox Therapeutics Ltd, a pioneering biotechnology company dedicated to developing targeted cancer therapies, and Vernalis (R&D) Ltd, a renowned subsidia...

February 22, 2024 | News

Biocytogen and Gilead Forge Landmark Collaboration to Harness Fully Human Antibody Library for Therapeutic Innovations

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a leading biotechnology company, announced a significant coll...

February 20, 2024 | News

AffaMed's NDA for DEXTENZA Accepted by Singapore HSA for Post-Surgery Ocular Treatment

AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products&...

February 19, 2024 | News

PharusDx Secures Exclusive License for Breakthrough Pancreatic Cancer Biomarkers from City of Hope

Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...

February 16, 2024 | News

Cathay Biotech and 3P.COM Forge Groundbreaking Joint Venture to Propel Sustainable Composite Innovations

In a strategic move towards sustainable innovation, Cathay Biotech Inc. of China and 3P.COM Co. Limited of South Korea have signed a landmark joint venture...

February 09, 2024 | News

Innovent Biologics Advances Novel Weight Management Drug Mazdutide with NDA Acceptance in China

This groundbreaking achievement marks mazdutide as the first GLP-1R/GCGR dual agonist to successfully complete Phase 3 trials in support of an NDA ...

February 08, 2024 | Regulatory

Complete Genomics and seqWell Partner to Enhance DNA Sequencing Solutions

The collaboration will focus on ensuring compatibility between seqWell-developed products and the entire Complete Genomics next-generation sequencing (NGS)...

February 08, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

January 26, 2024 | Interview

PRISM BioLab Secures 1.5 Billion Yen in Series C Funding for Advancing Protein-Protein Interaction Technologies

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

January 25, 2024 | News

PeproMene Bio Reports Successful B-ALL Treatment in Phase 1 Trial at City of Hope

This result adds to the presentation of PeproMene Bio's clinical trial of PMB-CT01 in relapsed/refractory non-Hodgkin's lymphoma at last month's Ameri...

January 18, 2024 | News

FUST Lab's DEBREX Nano-Emulsion Equipment Launches in Japan

Dispersion/emulsification technology (technology for mixing two or more immiscible substances) is a key technology used in various productions such as cosm...

January 16, 2024 | News

Novogene Expands Global Presence with Increased PacBio Revio Fleet for Enhanced Long-Read Sequencing Applications

Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...

January 10, 2024 | News

Stay Connected